Core Insights - Illumina has launched Illumina Connected Multiomics, a cloud-based platform designed to analyze and visualize multiomic and multimodal biological data, addressing the growing complexity of multiomic datasets [1][3][4] Product Features - Connected Multiomics integrates various biological data types, including transcriptomics, genomics, proteomics, and epigenetics, into a single platform, which reduces time, cost, and complexity for researchers [1][4] - The platform allows for the aggregation of thousands of multiomic samples from both Illumina and third-party assays, providing reproducible results and interactive visualizations [4][5] - AI-enabled features, such as PrimateAI and PromoterAI, enhance variant interpretation by filtering out background mutations and highlighting significant multiomic signals early in the analysis [4] User Experience - The software has been positively received by early access users, including oncology researchers at the University of Colorado Anschutz Medical School, who noted its user-friendliness and ability to focus on biological insights rather than technical challenges [3][7] - The platform is designed to be approachable for biologists while still powerful enough for bioinformaticians, facilitating a more efficient discovery process [3][6] Industry Impact - Illumina aims to establish itself as a leader in multiomic solutions, leveraging its advanced sequencing platforms to support precision health discoveries and accelerate breakthroughs in biology and drug development [6][7]

Core Insights - 10x Genomics has launched Xenium Protein, the first fully integrated spatial multiomic assay that allows simultaneous RNA and protein detection in the same cell and tissue section, enhancing biological insights without the need for data integration from multiple technologies [1][2] Group 1: Product Features - Xenium Protein expands the Xenium Spatial platform with ready-to-use protein subpanels that work seamlessly with RNA panels, focusing on proteins involved in cell growth, signaling, and immune response, which are crucial for studying cancer and immunology [2][4] - The new assay simplifies experimental design by reducing the need for separate workflows or sample sections, allowing researchers to capture both RNA and protein data in a single automated run, thus accelerating the pace of discoveries [3][4] Group 2: Industry Impact - Integrated multiomic analysis is essential for advancing the understanding of complex diseases and accelerating therapeutic discovery, as highlighted by industry experts [2][4] - Early access customers are already utilizing Xenium Protein for various research applications, from early discovery to large-scale atlasing efforts, indicating its broad applicability in the field [3]